Contemporary view to prophylactic salpingectomy
Abstract
The research of 51 doctors opinions from different regions of the Russian Federation and the near abroad (Kyrgyzstan) with respect to prophylactic salpingectomy. This study demonstrated the awareness of doctors regarding the current views on prophylactic salpingectomy. According to the results of the main part of the questionnaire 35 of 51 (68.6%) responded that they made bilateral salpingectomy when performing a hysterectomy without oophorectomy for benign disease: 22 of 35 (62.9%) to reduce the risk of developing cancer, 16 of 35 (45.7%) to reduce the risk of formation of hydrosalpinx, 6 of 35 (17.1%) in order to reduce the risk of pelvic pain and 5 doctors (14.3%) to reduce the risk of reoperation. Some questions from the main part of the questionnaire suggests selecting one or more answers.
About the Authors
A. A. Popov
Moscow regional scientific research institute of obstetrics and gynecology
Russian Federation
Russian Federation
B. A. Slobodyanyuk
Moscow regional scientific research institute of obstetrics and gynecology
Russian Federation
Russian Federation
A. A. Koval
Moscow regional scientific research institute of obstetrics and gynecology
Russian Federation
Russian Federation
R. A. Barto
Moscow regional scientific research institute of obstetrics and gynecology
Russian Federation
Russian Federation
References
1. Bartz D., Greenberg J.A. Sterilization in the United States // Rev obstet gynecol. - 2008. - № 1. - Р. 23-32.
2. Chan A., Gilks B., Kwon J., Tinker A.V. New insights into the pathogenesis of ovarian carcinoma. Time to rethink ovarian cancer screening // Obstet gynecol. - 2012. - № 120. - Р. 935-940.
3. Crum C.P., Drapkin R., Kindelberger D., Medeiros F., Miron A., Lee Y. Lessons from BRCA: the tubalfimbria emerges as an origin for pelvic serous cancer // Clin. med. res. - 2007. - № 5. - Р. 35-44.
4. Crum C.P., Drapkin R., Miron A., et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis // Cur. opin. obstet. gynecol. - 2007. - № 19. - Р. 3-9.
5. Crum C.P., McKeon F.D., Xian W. BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis // Int. j. gynecol. cancer. - 2012. - № 22. - Р. 29-34.
6. Dar P., Sachs G.S., Strassburger D., Bukovsky I., Arieli S. Ovarian function before and after salpingectomy in artificial reproductive technology patients // Hum. reprod. - 2000. - № 15. -Р. 142-144.
7. Dietl J., Wischhusen J., Hdusler S.F. The post-reproductive fallopian tube: better removed? // Hum. reprod. - 2011. -№ 26. - Р. 2918-2924,doi:10. 1093/humrep/der274.
8. Findley A.D., Siedhoff M.T., Hobbs K.A., Steege J.F., Carey E.T., McCall C.A., Steiner A.Z. Shortterm effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial // Fertil. steril. - 2013. - Dec. № 100 (6). - Р. 1704-1708. doi: 10.1016/j. fertnstert. 2013.07.1997. Epub 2013 Aug 29. PMID 23993887.
9. Ghezzi F., Cromi A., Siesto G., Bergamini V., Zefiro F., Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? // BJOG. - 2009. - № 116. - Р. 589-593.
10. Gill S.E., Mills B.B. Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization // J. minim. invasive. gynecol. - 2013. - Jul-aug. № 20 (4). -Р. 517-521. doi: 10. 1016/j.jmig. 2013.02.010.
11. Kurman R.J., Shih I.M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory // Am. j. surg. pathol. - 2010. - № 34. - Р. 433-443.
12. Kwon J.S., Tinker A., Pansegrau G., McAlpine J., Housty M., McCullum M., et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers // Obstet. gynecol. - 2012. - Р. 1-11.
13. Lawrie T.A., Nardin J.M., Kulier R., Boulvain M. Techniques for the interruption of tubal patency for female sterilization // Cochrane. database. syst. rev. - 2011. - № 2. - CD003034.
14. Manchanda R., Abdelraheim A., Johnson M., Rosenthal A., Benjamin E., Brunell C., et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status // BJOG. - 2011. - № 118. - Р. 814-824.
15. Medeiros F., Muto M.G., Lee Y., et al. The tubalfimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome // Am. j. surg. pathol. - 2006. - № 30. -Р. 230-236.
16. Morelli M.I., Venturella R., Mocciaro R., Di Cello A., Rania E., Lico D., D'Alessandro P., Zullo F. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere // Gynecol. oncol. - 2013. - Jun. № 129 (3). -Р. 448-451. doi: 10.1016/ j.ygyno. 2013.03.023. Epub 2013 Apr 2.
17. Morse A.N., Hammer R.A., Walter A.J., Baker S., Magtibay P.M. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? // Am. j. obstet. gynecol. - 2002. - № 187. - Р. 1483-1486.
18. Morse A.N., Schroeder C.B., Magrina J.F., Webb M.J., Wollan P.C., Yawn B.P. The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study // Am. j. obstet. gynecol. - 2006. -№ 194. - Р. 1273-1276.
19. Parker W.H., Broder M.S., Chang E., Feskanich D., Farquhar C., Liu Z., et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study // Obstet. gynecol. - 2009. - № 113. - Р. 1027-1037.
20. Petri E.A., Nahas E.A., Pontes A. et al. Effect of total abdominal hysterectomy on ovarian blood supply in women of reproductive age // J. ultrasound med. - 2005. - V. 24. № 2. - P. 169-174.
21. Powell C.B., Chen L.M., McLennan J., Crawford B., Zaloudek C., Rabban J.T., et al. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical pathological protocol // Int. j. gynecol. cancer. - 2011. - № 21. - Р. 846-851.
22. Repasy I., Lendvai V., Koppan A., Bodis J., Koppan M. Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome // Eur. j. obstet. gynecol. reprod. biol. - 2009. - № 144. - Р. 64-67.
23. Salvador S., Rempel A., Soslow R.A., Gilks B., Hunsman D., Miller D. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma // Gynecol oncol. - 2008. - № 110. - Р. 408-417.
24. Sezik M., Ozkaya O., Demir F., Sezik H.T., Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow // J. obstet. gynaecol. res. - 2007. - № 33. - Р. 863-869.
25. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., et al. ARID1A mutations in endometriosis-associated ovarian carcinomas // N. engl. j. med. - 2010. - № 363. -Р. 1532-1543.
Review
For citations:
Popov A.A., Slobodyanyuk B.A., Koval A.A., Barto R.A. Contemporary view to prophylactic salpingectomy. Kuban Scientific Medical Bulletin. 2015;(2):122-128. (In Russ.)
Views:
248
Email this article 